Overview

A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Abdominal Surgery

Status:
NOT_YET_RECRUITING
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
The primary objective is to evaluate the analgesic efficacy and safety of IV YZJ-4729 Tartrate Injection in patients with acute postoperative pain following abdominal surgery.
Phase:
PHASE3
Details
Lead Sponsor:
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.